SOURCE: annual_report_text (1).txt
CHUNK: 565 of 1106
SIZE: 549 characters
PREVIOUS: chunk_0564_annual_report_text (1).txt
NEXT: chunk_0566_annual_report_text (1).txt
------------------------------
sures closely monitored. The balance sheet 
remains strong, providing the Group with 
significant flexibility for both organic and 
inorganic growth. IBA reiterates its previously announced mid-term 
guidance, based on the assumption that macro-
economic factors normalize over the coming 
years: supply chain issues stabilize, inflation 
drops towards 3%, and challenges accessing 
certain regions reduce. In addition, guidance is 
on the basis that order intake remains solid, especially in the Proton Therapy and Industrial 
Solutions businesses.